Wyniki mojej kotki z połowy lutego:
Nazwa parametru wynik zakres normy jednostka
Geriatric Profile
T4 (total T4) 82.4 + 10 - 60 nmol/l 1)
<10 nmol/l Subnormal
10 - 60 nmol/l Normal
30 - 60 nmol/l Grey zone in old or symptomatic cats
>60 nmol/l Consistent with hyperthyroidism
Kidney:
Urea (BUN) 22.4 + 5.7 - 13.5 mmol/l
Creatinine 271 + < 168 umol/l
SDMA (EIA) 36 + 0 - 14 ug/dl 2)
IDEXX SDMA is a new kidney biomarker; results >14ug/dl are suggestive of
kidney disease. For more information visit
http://www.idexxsdma.comSodium 154 147 - 159 mmol/l
Chloride 120 109 - 129 mmol/l
Potassium 4.7 3.3 - 5.8 mmol/l
Inorganic Phosphate 2.1 0.8 - 2.2 mmol/l
Liver:
Bilirubin 3.1 < 6.8 umol/l
ALT (GPT) 262 + < 175 U/l
Alkaline phosphatase 80 + < 73 U/l
GGT 2 < 5 U/l
AST (GOT) 57 < 71 U/l
GLDH 18 + < 11 U/l
Total protein 68 59 - 87 g/l
Albumin 34 27 - 44 g/l
Globulin 34 29 - 54 g/l
Albumin/Globulin-Ratio 0.99 > 0.57
Pancreas:
Glucose 5.5 3.5 - 7.8 mmol/l
Cholesterol 6.4 < 8.5 mmol/l
Cholesterol (Fasting cats with regular body weight): < 5.2 mmol/l
Fructosamine 191 190 - 365 umol/l
Muscle:
CK 552 + < 542 U/l
LDH 287 + < 182 U/l
Calcium 2.7 2.2 - 2.9 mmol/l
Magnesium 0.9 0.6 - 1.1 mmol/l
Triglycerides 0.7 0.2 - 4.9 mmol/l
Triglyerides (Fasting cats with regular body weight): 0.2 - 1.1 mmol/l
Haemogram
Leukocytes 3.5 - 6 - 11 G/l
In stressed cats up to 18
Erythrocytes 8.7 5 - 10 T/l
Haemoglobin concentration 13.4 9 - 15 g/dl
Packed cell volume (PCV) 43 28 - 45 %
MCV 50 40 - 55 fl
MCH 15 13 - 17 pg
MCHC 31 31 - 35 g/dl
Thrombocytes 205 150 - 550 G/l
Reticulocytes (relative) 0.33 %
Reticulocytes (absolute) 29000 /ul
Degree of bone marrow response (Reticulocytes/ul):
< 50.000 Normal if nonanemic
< 50.000 Inadequate if anemic
50.000-75.000 Mild regeneration
75.000-175.000 Moderate regeneration
> 175.000 Marked regeneration
Differential blood count
Basophils 0 0 - 1 %
Eosinophils 2 0 - 6 %
Band neutrophils 0 0 - 3 %
Segmented neutrophils 69 50 - 75 %
Lymphocytes 29 15 - 50 %
reactive lymphocytes +
Monocytes 0 0 - 4 %
Basophils (absolute) 0 /ul 3)
Eosinophils (absolute) 71 0 - 600 /ul
Band neutrophils (absolute) 0 0 - 300 /ul
Segmented neutrophils (abs) 2436 - 3000 - 11000 /ul
Lymphocytes (absolute) 1024 1000 - 6000 /ul
Monocytes (absolute) 0 0 - 500 /ul
Atypical cells 0 0 %
Anisocytosis 0 0
Polychromasia 0 0
Gastrointestinal diseases
Add-on
Feline Specific Pancreatic Lipase
3.9 + ug/l 4)
Folic acid
(ECLIA) 50.9 + 25.2 - 49.0 nmol/l
Vitamin B12
(ECLIA) 345 199 - 984 pmol/l
Uwagi / Note:
1)
Cats with subnormal T4 values are almost exclusively euthyroid sick or
overtreated for their hyperthyroidism. Older cats with consistent clinical signs
and T4 values in the grey zone may have early hyperthyroidism or a concurrent
non-thyroidal illness. Hyperthyroidism may be confirmed by repeating the test
in 2-8 weeks or by adding on a free T4 (Equilibrium Dialysis).
Following treatment with methimazole, T4 values will generally fall within the
lower end of the reference range.
2)
IDEXX SDMA is a new test to help evaluate kidney function. It increases
earlier than creatinine in some animals with chronic kidney disease. Unlike
creatinine, SDMA is not impacted by lean body mass.
Both SDMA and creatinine are increased which indicates kidney function
is likely impaired. A complete urinalysis should be performed to evaluate for
inappropriate specific gravity, proteinuria and other evidence of kidney
disease.
.
3)
Basophils up to 200/ul are considered normal in the literature.
4)
<= 3.5 ug/L Serum Spec fPL concentration is in the normal range. It is
unlikely that the cat has pancreatitis. Investigate for other
diseases that could cause observed clinical signs.
3.6 - 5.3 ug/L Serum Spec fPL concentration is increased. The cat may
have pancreatitis and Spec fPL should be reevaluated in two
weeks if clinical signs persist. Investigate for other diseases
that could cause observed clinical signs.
>= 5.4 ug/L Serum Spec fPL concentration is consistent with pancreatitis.
The cat most likely has pancreatitis. Consider investigating
for risk factors and concurrent diseases (e.g., IBD, hepatitis,
diabetes mellitus). Periodic monitoring of Spec fPL may help
assess response to therapy.
*** Wynik koncowy / Final report *** validated by Dr. Haas (Tierarzt)